Director/PDMR Shareholding

RNS Number : 7287O

Epistem Holdings plc

02 July 2010

 



Epistem Holdings Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors have each increased their beneficial interest in the Company by 282 ordinary shares of 1.5p each. These shares were acquired in tranches at the end of April, May and June 2010 at prices of 417p, 415p and 363p respectively.

The current beneficial interests of the executive Directors are set out below:

Matthew Walls                             7,183                                   (0.09%)

Dr Catherine Booth                  981,538                                  (12.37%)

Dr Ged Brady                              1,538                                   (0.02%)

Dr Jeffrey Moore                        16,038                                   (0.20%)          

John Rylands                            191,436                                   (2.41%)

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

KBC Peel Hunt Ltd.

James Steel / Vijay Barathan                                                     [phone]

 

END

 

 

RDSGCGDRDUGBGGD